A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases

A Multi-centre Real-world Non-interventional Observational Study to Explore Prognoses of the Patients With Non-small Cell Lung Cancer Complicated With Oligometastases

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03427541

Enrollment

1000

Registered

2018-02-09

Start date

2017-12-31

Completion date

2018-04-30

Last updated

2018-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Small Cell Lung Cancer

Keywords

Chinese, non-small cell lung cancer, oligometastases

Brief summary

An observational study to explore prognoses and clinical treatments of the patients with non-small cell lung cancer complicated with oligometastases

Detailed description

A multi-centre real-world non-interventional observational study to explore prognoses and clinical treatments of the patients with non-small lung cancer complicated with oligometastases

Interventions

PROCEDURESurgeries

Surgeries

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Pathologically diagnosed patients with non-small cell lung cancer; * Tumor metastases in one organ (no more than 3 metastases);

Exclusion criteria

* Patients with intrapulmonary metastases or multiple primary tumors; * Patients with pleural dissemination or invasion of extrapulmonary organs; * Patients with supraclavicular lymph node metastasis; * Patients with systematic diseases that would influence patient survivals; * Patients with no records for visits;

Design outcomes

Primary

Measure	Time frame	Description
Overall survival	2014 - 2017	Overall survival

Secondary

Measure	Time frame	Description
Disease-free survival	2014 - 2017	Disease-free survival

Countries

China

Contacts

Primary ContactHaiying Yang, PhD

celineyang@linkdoc.com0086-010-62680809

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026